Brain Cancer Trial, Recruiting NCT06607029 Sponsor: Beijing Tiantan Hospital Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT06607029
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are scheduled to have brain surgery (a craniotomy) to remove or treat a tumour in the upper part of the brain, performed under general anaesthetic
  • People aged between 18 and 65 years old
  • People whose overall physical health has been assessed by an anaesthetist as falling within a standard acceptable range (ASA physical status I to III — confirm with trial site if unsure what this means for your situation)
  • People who have signed a consent form agreeing to take part

Who may not be able to join:

  • People with a body mass index (BMI) of 35 or higher
  • People with severe liver or kidney problems
  • People who have difficulties with memory, thinking, or communication that would make completing assessments difficult
  • People whose pre-surgery brain scan (MRI) shows the central structures of the brain have shifted more than 5 mm to one side
  • People who will need nerve or brain activity monitoring (electrophysiological monitoring) during their surgery
  • People who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 010-59976660

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Tiantan Hospital
Registry
ClinicalTrials.gov
Start date
21 October 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

the quality of recovery-15(QoR-15) score on the second day after surgery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov